Rhythm Pharmaceuticals In... (RYTM)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

55.24

-0.07%

After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	77.43M	23.64M	3.15M	-	-	-	-	-	-	-	-	-
Cost of Revenue	9.30M	2.13M	599.00K	690.00K	834.00K	442.00K	223.00K	144.00K	-	-	-	-
Gross Profit	68.13M	21.50M	2.56M	-690.00K	-834.00K	-442.00K	-223.00K	-144.00K	-	-	-	-
Operating Income	-184.36M	-179.16M	-170.06M	-136.57M	-146.00M	-78.42M	-32.41M	-25.91M	-10.57M	-6.49M	-21.45M	-18.14M
Interest Income	13.95M	4.03M	447.00K	2.58M	5.27M	4.35M	566.00K	33.00K	-	-	-	-
Pretax Income	-184.11M	-181.12M	-69.61M	-134.00M	-140.73M	-74.06M	-33.71M	-25.87M	-11.07M	-6.49M	-21.43M	-18.13M
Net Income	-184.68M	-183.08M	-68.01M	-130.73M	-134.62M	-74.06M	-33.71M	-25.87M	-11.07M	-6.49M	-21.43M	-18.13M
Selling & General & Admin	117.53M	92.03M	68.49M	46.13M	36.55M	28.08M	9.52M	6.31M	3.42M	1.21M	3.43M	2.46M
Research & Development	134.95M	108.63M	104.13M	90.45M	109.45M	50.34M	22.89M	19.59M	7.15M	5.28M	18.02M	15.68M
Other Expenses	-	-790.00K	100.00M	-	-	-	-1.86M	-	-500.00K	-	-	-
Operating Expenses	252.48M	200.66M	172.61M	136.57M	146.00M	78.42M	32.41M	25.91M	10.57M	6.49M	21.45M	18.14M
Interest Expense	13.89M	5.20M	-	-	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	261.79M	202.79M	173.21M	136.57M	146.00M	78.42M	32.41M	25.91M	10.57M	6.49M	21.45M	18.14M
Income Tax	564.00K	1.96M	-1.60M	-3.27M	-6.11M	4.35M	1.07M	-	-	-	-	-
Shares Outstanding (Basic)	57.67M	52.12M	49.60M	44.13M	36.42M	31.00M	13.27M	16.73M	16.73M	10.20M	50.27M	50.27M
Shares Outstanding (Diluted)	57.67M	52.12M	49.60M	44.13M	36.42M	31.00M	13.27M	16.73M	16.73M	10.20M	50.27M	50.27M
EPS (Basic)	-3.2	-3.51	-1.37	-2.96	-3.7	-2.39	-2.54	-1.55	-0.66	-0.64	-0.43	-0.36
EPS (Diluted)	-3.2	-3.51	-1.37	-2.96	-3.7	-2.39	-2.54	-1.55	-0.66	-0.64	-0.43	-0.36
EBITDA	-168.46M	-174.51M	-68.45M	-135.88M	-145.17M	-77.97M	-32.19M	-25.76M	-10.07M	-	-21.41M	-18.12M
Depreciation & Amortization	1.76M	1.40M	1.16M	690.00K	834.00K	442.00K	223.00K	144.00K	500.00K	6.49M	20.00K	17.00K